Cantor Fitzgerald Maintains a Buy Rating on Crinetics Pharmaceuticals (CRNX)
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) is one of the best biotech stocks with high potential. On October 1, Cantor Fitzgerald analyst…
Tag: CRNX
JMP Backs Crinetics Pharmaceuticals, Inc. (CRNX) With Big Upside Post-Approval
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) is among the best fast money stocks to buy now. Analysts at JMP Securities have reaffirmed…